bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
2.060
+0.010 (0.49%)
At close: Nov 7, 2025, 4:00 PM EST
2.220
+0.160 (7.77%)
After-hours: Nov 7, 2025, 7:57 PM EST
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $9.25 million as of November 7, 2025. Its market cap has decreased by -58.79% in one year.
Market Cap
9.25M
Enterprise Value
9.12M
1-Year Change
-58.79%
Ranking
Category
Stock Price
$2.06
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $9.25M, a decrease of -79.46%. That is a compound annual growth rate of -39.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 9.25M | -34.79% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
| Sep 1, 2022 | 45.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 816.55B |
| Johnson & Johnson | 449.48B |
| AbbVie | 385.96B |
| UnitedHealth Group | 288.61B |
| AstraZeneca | 263.38B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.79B |
| Thermo Fisher Scientific | 215.01B |